In 1985, recombinant human growth hormone was approved for the treatment of children with growth hormone deficiency. This therapeutic agent was among the first drugs to be produced by recombinant ...

Until observations can be made in patients with hypoglycemia of diverse origins it is presumptuous to assume that treatment with human growth hormone will be uniformly successful. However ...

Institute of Legal Medicine, Lausanne, Switzerland; martial.saugy{at}chuv.ch Background and objectives: Recombinant human growth hormone (rhGH) has been on the list of forbidden substances since ...

In January 2024, researchers in the U.K. published a study in the journal Nature Medicine proposing that several people who received cadaveric growth hormone between 1959 and 1989 as a treatment ...

It is also approved in the US for children aged one year and above with growth failure due to inadequate secretion of growth ...

From enhancing wound healing to combating neurodegeneration and cancer, growth hormone-releasing hormone and its analogs reveal groundbreaking roles that could redefine future therapies.

"Ascendis Pharma submits sBLA for growth hormone deficiency therapy" was originally created and published by Pharmaceutical ...

Purpose: Increased blood lactate concentration has been suggested as a primary stimulus for the exercise-induced growth hormone response (EIGR). Patients with McArdle disease are unable to produce ...